Select for export Psilocybin therapy for adult females with anorexia nervosa: pilot study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1192/bjp.2026.10687 PubMed 42414058 Copy citation Copy BibTeX The British Journal of Psychiatry 2026-07-07 Douglass HM, Spriggs MJ, Godfrey K, Danby JL, de Magalhaes FJC, Macdonald L New this week Europe PMC Published psilocybin Eating DisordersHeadache / MigraineClinical Trial Clinical Trial More
Select for export A lexicon for psychedelic research and treatment Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/20503245251380511 Copy citation Copy BibTeX Drug Science Policy and Law 2025-08-31 David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida OpenAlex Published psilocybin DepressionPharmacologyMicrodosing Clinical Trial More
Select for export Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/j.eclinm.2024.102799 PubMed 39764567 Copy citation Copy BibTeX EClinicalMedicine 2024-09-22 David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi OpenAlex Published psilocybin DepressionAnxietyChronic Pain Randomized Controlled Trial More
Select for export Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1177/02698811241237870 PubMed 38520045 Copy citation Copy BibTeX Journal of Psychopharmacology 2024-03-21 David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris OpenAlex Published psilocybin DepressionAnxietyChronic Pain Clinical Trial More
Select for export Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1038/s41598-023-40856-5 PubMed 37608057 Copy citation Copy BibTeX Scientific Reports 2023-08-21 Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin J. Mallard, Daniel E. Roberts, David Erritzøe OpenAlex Published psilocybin Receptor PharmacologyMystical ExperienceSafety Other More
Select for export Psilocybin with psychological support for treatment-resistant depression: six-month follow-up. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1007/s00213-017-4771-x PubMed 29119217 Copy citation Copy BibTeX Psychopharmacology 2017-11-07 Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE Europe PMC Published psilocybin DepressionClinical TrialTreatment-Resistant Depression Clinical Trial More
Select for export Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study. Abstract available at the source but not redistributed here. Read at source. Details DOI 10.1016/s2215-0366(16)30065-7 PubMed 27210031 Copy citation Copy BibTeX The Lancet Psychiatry 2016-05-16 Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M Europe PMC Published psilocybin DepressionAnxietyAddiction Other More